Christopher S. Downs
Equibles does not estimate personal net worth.
About Christopher S. Downs
Earlier roles on record: CFO at CNS Pharmaceuticals, Inc. (CNSP) until March 2, 2026. The proxy statement of CNS Pharmaceuticals, Inc. reports total compensation of $621,050 for Christopher S. Downs in fiscal 2024, including a base salary of $340,000. Disclosed compensation is on record for 6 fiscal years.
Affiliation history
-
Start not stated–2026-03-02
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | CNS Pharmaceuticals, Inc. (CNSP) | CFO | $340,000 | $621,050 |
| 2023 | CNS Pharmaceuticals, Inc. (CNSP) | CFO | $340,000 | $401,515 |
| 2022 | CNS Pharmaceuticals, Inc. (CNSP) | CFO | $340,000 | $481,224 |
| 2021 | CNS Pharmaceuticals, Inc. (CNSP) | CFO | $340,000 | $480,475 |
| 2020 | CNS Pharmaceuticals, Inc. (CNSP) | CFO | $300,000 | $790,999 |
| 2019 | CNS Pharmaceuticals, Inc. (CNSP) | CFO | $40,000 | $1,154,115 |
Recent activity
No call appearances or filed executive changes recorded yet.